rhabdomyolysis glp 1 GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes GLP-1-based therapies for type 2
Description
75% of US consumers say GLP-1s are a useful tool, not a magic cure - but 61% of users admit it can feel like cheating. The stigma is fading fast
Higher protein intake provides the raw materials for muscle maintenance
CMS is proposing temporary expansions of Medicare and Medicaid coverage of GLP-1s for obesity through demonstration programs CMS initially proposed a two-step approach to expanding coverage of GLP-1s for obesity in Medicare a temporary payment demonstration for 2026, known as the Medicare GLP-1 Bridge, and a new Center for Medicare and Medicaid Innovation (CMMI) model, known as the BALANCE Model, that was originally scheduled to begin in January 2027 and end in December 2031
To find something useful you take out one toxin at a time and test it, looking for one that does something good
Meanwhile, 83% find products specifically marketed as supportive of people on GLP-1 medications appealing
